Anti-Lung Cancer and Cell Migration Inhibition Properties of Ethyl Acetate Extract of Selaginella doederleinii Towards HTB-183 Cells through In Silico and In Vitro Approach
Abstract
Continuous research and development to obtain novel anti-lung cancer agents is essential, considering the high prevalence and mortality of the disease. The biflavonoid compounds of Selaginella doederleinii showed significant anticancer activities. This study aims to determine the cytotoxic and cell migration inhibition properties of ethyl acetate extract of Selaginella doederleinii (EAESD) against HTB-183 cells through in silico and in vitro methods. This study started with extraction and then identified biflavonoids in EAESD by HPLC. In vitro analysis was conducted through MTT Assay to observe the cytotoxic properties of EAESD and Wound Scratch Healing Assay to observe its cell migration inhibitory properties. In silico studies to obtain the potential anti-lung cancer compounds and their protein targets were conducted through bioinformatics, combining PASS analysis, Swiss Target Prediction, and STITCH. The obtained compounds and protein targets were analyzed in Molecular Docking to evaluate the binding affinities. The result showed that EAESD contained biflavonoid compounds, exhibited cytotoxic activity with an IC50 value of 190 μg/ml, and inhibited the migration rate of HTB-183 cells. Based on in silico analysis, the three biflavonoids with the highest potential of antilung cancer activity along with their target protein are robustaflavone 7,4-dimethyl ether with EGFR, heveaflavone with ESR1, and 7,4',7'',4'''-tetra-O-methyl-amentoflavonewith TNF. All compounds can bind to each protein target with the docking score -9.2 kcal/mol, -9.5 kcal/mol, and -6.5 kcal/mol, respectively. This study suggested preliminary data regarding the potential of Selaginella doederleinii to inhibit the proliferation and migration of the HTB-183 cell line of lung cancer.
Keywords: Selaginella doederleinii, HTB-183, cytotoxicity, cell migration, in silico analysis.
Full Text:
PDFReferences
Adam, S.H., Darrag, A., and Abdelsalam, N., 2021, Comparative evaluation of the cytotoxic effect of different intracanal medicaments, Dental Science Updates, 2(2), 123-133. CrossRef
Ali, A., Banerjee, S., Kamaal, S., Usman, M., Das, N., Afzal, M., et al., 2021, Ligand substituent effect on the cytotoxicity activity of two new copper (ii) complexes bearing 8-hydroxyquinoline derivatives: Validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer), RSC advances, 11(24), 14362-14373. CrossRef
American Cancer Society, 2018, Cancer Facts and Figures 2018. Accessed at 7 June 2022, from Cancer: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Link
Antonioli, L., Blandizzi, C., Pacher, P., Guilliams, M., and Haskó, G., 2019, Rethinking communication in the immune system: the quorum sensing concept, Trends in immunology, 40(2), 88-97. CrossRef
Arthur, D.E., 2019, Molecular docking studies of some topoisomerase II inhibitors: Implications in designing of novel anticancer drugs, Radiology of Infectious Diseases, 6(2), 68-79. CrossRef
Arthur, D.E., and Uzairu, A., 2019, Molecular docking studies Phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit, Journal of King Saud University-Science, 31(4), 1151-1166. CrossRef
Bukowski, K., Kciuk, M., and Kontek, R., 2020, Mechanisms of Multidrug Resistance in Cancer Chemotherapy, International Journal of Molecular Science, 21(3233), 1-24. CrossRef
Chaubah, M.A.L., Bontes, B.W., and Mulachelah, N.A., 2019, Molecular docking of polycyclic aromatic hydrocarbons as potentially carcinogenic molecules through binding with aryl hydrocarbon receptor, Journal of Smart Bioprospecting and Technology, P-ISSN, 2686, 0805. CrossRef
Chen, W., Cheng, H., and Xia, W., 2022, Construction of Polygonatum sibiricum Polysaccharide Functionalized Selenium Nanoparticles for the Enhancement of Stability and Antioxidant Activity, Antioxidants, 11(2), 240. CrossRef
Chowdhury, S.A., and Bhattacharjee, S.C., 2021, In Silico Biological Profile Prediction of Some Selectively Synthesized Acyl Rhamnopyranosides, Journal of Scientific Research, 13(2), 657-668. CrossRef
Fakih, T.M., Ramadhan, D.S.F., and Darusman, F., 2021, In silico activity identification of cyclo peptide alkaloids from Zizyphus spina-christi species against Sars-Cov-2 main protease, Jurnal Biodjati, 6(1), 71-81. CrossRef
Filimonov, D.A., Lagunin, A.A., Gloriozova, T.A., Rudik, A.V., Druzhilovskii, D.S., Pogodin, P.V., and Poroikov, V.V., 2014, Prediction of The Biological Activity Spectra of Organic Compounds Using The Pass Online Web Resource, Chemistry of Heterocyclic Compounds, pp. 444–457. CrossRef
Gallaher, J.A., Brown, J.S., and Anderson, A.R., 2019, The impact of proliferation-migration tradeoffs on phenotypic evolution in cancer, Scientific reports, 9(1), 1-10. CrossRef
Gao, X., Cai, Y., Wang, Z., He, W., Cao, S., Xu, R., and Chen, H., 2019, Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective, Journal of Translational Medicine, 17, 1-15. CrossRef
García-Ortegón, M., Simm, G.N., Tripp, A.J., Hernández-Lobato, J.M., Bender, A., and Bacallado, S., 2022, DOCKSTRING: easy molecular docking yields better benchmarks for ligand design, Journal of chemical information and modeling, 62(15), 3486-3502. CrossRef
Gong, K., Guo, G., Beckley, N., Zhang, Y., Yang, X., Sharma, M., and Habib, A.A., 2021, Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment, Neoplasia, 23(2), 189-196. CrossRef
Gonzalvez, F., Vincent, S., Baker, T.E., Gould, A. E., Li, S., Wardwell, S.D., et al., 2021, Mobocertinib (TAK-788): a targeted inhibitor of EGFR exon 20 insertion mutants in non–small cell lung cancer, Cancer discovery, 11(7), 1672-1687. CrossRef
Grinshpun, A., Chen, V., Sandusky, Z.M., Fanning, S.W., and Jeselsohn, R., 2023, ESR1 activating mutations: From structure to clinical application, Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1878(1), 188830. CrossRef
Han, J., Xie, C., Liu, B., Wang, Y., Pang, R., Bi, W., et al., 2023, Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c‐Myc‐mediated glycolysis, Cancer Science, 114(12), 4535–4547. CrossRef
Hsu, P.C., Jablons, D.M., Yang, C.T., and You, L., 2019, Epidermal growth factor receptor (EGFR) pathway, yes-associated protein (YAP) and the regulation of programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), International Journal of Molecular Sciences, 20(15), 3821. CrossRef
International Agency for Research on Cancer, 2020, Cancer Incident in Indonesia. Diakses pada 6 Mei 2022, from Global Cancer Observatory: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf. Link
Jamkhande, P.G., Pathan, S.K., and Wadher, S.J., 2016, In silico PASS analysis and determination of antimycobacterial, antifungal, and antioxidant efficacies of maslinic acid in an extract rich in pentacyclic triterpenoids, International Journal of Mycobacteriology, 5(4), 417-425. CrossRef
Kang, F., Zhang, S., Chen, D., Tan, J., Kuang, M., Zhang, J., et al., 2021, Biflavonoids from Selaginella doederleinii as potential antitumor agents for intervention of non-small cell lung cancer, Molecules, 26(17), 5401. CrossRef
Kristiani, E.B.E., Kasmiyati, S., and Herawati, M., 2021, The cytotoxic and apoptotic effects of wild and polyploidy genotype of Artemisia cina extracts on the WiDr colon and HTB-183 lung cancer cell lines, Biodiversitas Journal of Biological Diversity, 22(7), 2844-2852. CrossRef
Kumar, S., Abbas, F., Ali, I., Gupta, M.K., Kumar, S., Garg, M., and Kumar, D., 2023, Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer, Phytomedicine plus, 3(2), 100419. CrossRef
Li, D., Qian, Y., Tian, Y.J., Yuan, S. M., Wei, W., and Wang, G., 2017, Optimization of ionic liquid-assisted extraction of biflavonoids from Selaginella doederleinii and evaluation of its antioxidant and antitumor activity, Molecules, 22(4), 586. CrossRef
Li, S., Wang, X., Wang, G., Shi, P., Lin, S., Xu, D., et al., 2020, Ethyl acetate extract of Selaginella doederleinii hieron induces cell autophagic death and apoptosis in colorectal cancer via PI3K-Akt-mTOR and AMPKα-signaling pathways, Frontiers in Pharmacology, 11, 565090. CrossRef
Lin, S.-R., Chang, C.-H., Hsu, C.-F. H., Tsai, M.-J., Cheng, H., Leong, M. K., ., 2020, Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence, British Journal of Pharmacology, 177, 1409-1423. CrossRef
Martinotti, S., and Ranzato, E., 2019, Scratch wound healing assay, Epidermal cells: methods and protocols, 2109, 225-229. CrossRef
Mohamed, M.E., Tawfeek, N., Elbaramawi, S.S., Elbatreek, M.H., and Fikry, E., 2022, Agathis robusta bark extract protects from renal ischemia-reperfusion injury: phytochemical, in silico and in vivo studies, Pharmaceuticals, 15(10), 1270. CrossRef
Mohammadi Bazargani, M., Falahati-Anbaran, M., and Rohloff, J., 2021, Comparative analyses of phytochemical variation within and between congeneric species of Epilobium hirsutum and E. parviflorum: contribution of environmental factors, Front. Plant Sci., 11, 595190. CrossRef
Mohammadi, A., Mansoori, B., Duijf, P.H., Safarzadeh, E., Tebbi, L., Najafi, S., et al., 2021, Restoration of miR‐330 expression suppresses lung cancer cell viability, proliferation, and migration, Journal of cellular physiology, 236(1), 273-283. CrossRef
Mora Lagares, L., Minovski, N., Caballero Alfonso, A. Y., Benfenati, E., Wellens, S., Culot, M., et al., 2020, Homology modeling of the human P-glycoprotein (ABCB1) and insights into ligand binding through molecular docking studies, International Journal of Molecular Sciences, 21(11), 4058. CrossRef
Muema, F.W., Liu, Y., Zhang, Y., Chen, G., and Guo, M., 2022, Flavonoids from Selaginella doederleinii Hieron and their antioxidant and antiproliferative activities, Antioxidants, 11(6), 1189. CrossRef
O’Leary, C., Gasper, H., Sahin, K.B., Tang, M., Kulasinghe, A., Adams, M.N., et al., 2020, Epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC), Pharmaceuticals, 13(10), 273. CrossRef
Pijuan, J., Barceló, C., Moreno, D.F., Maiques, O., Sisó, P., Marti, R.M., et al., 2019, In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis, Frontiers in cell and developmental biology, 7, 107. CrossRef
Prava, J., and Pan, A., 2022, In silico analysis of Leishmania proteomes and protein-protein interaction network: Prioritizing therapeutic targets and drugs for repurposing to treat leishmaniasis, Acta Tropica, 229, 106337. CrossRef
Rajaei, N., Rahgouy, G., Panahi, N., and Razzaghi-Asl, N., 2023, Bioinformatic analysis of highly consumed phytochemicals as P-gp binders to overcome drug-resistance, Research in Pharmaceutical Sciences, 18(5), 505-516. CrossRef
Ramírez, D., and Caballero, J., 2018, Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data?, Molecules, 23(5), 1038. CrossRef
Ramos, A., Sadeghi, S., and Tabatabaeian, H., 2021, Battling chemoresistance in cancer: root causes and strategies to uproot them, International Journal of Molecular Sciences, 22(17), 9451. CrossRef
Rehman, N., and Qamar, S., 2022, Numerical Approximation of the Nonequilibrium Model of Gradient Elution Chromatography Considering Linear and Nonlinear Solvent Strength Models, ACS omega, 7(36), 31905-31915. CrossRef
Ren, M., Li, S., Gao, Q., Qiao, L., Cao, Q., Yang, Z., et al., 2023, Advances in the Anti-Tumor Activity of Biflavonoids in Selaginella, International Journal of Molecular Sciences, 24(9), 7731. CrossRef
Shen, B., Shangguan, X., Yin, Z., Wu, S., Zhang, Q., Peng, W., et al., 2021, Inhibitory effect of fisetin on α-glucosidase activity: Kinetic and molecular docking studies, Molecules, 26(17), 5306. CrossRef
Shivaleela, B., Srushti, S.C., Shreedevi, S.J., and Babu, R.L., 2022, Thalidomide-based inhibitor for TNF-α: designing and Insilico evaluation, Future Journal of Pharmaceutical Sciences, 8, 1-10. CrossRef
Sivasakthi, P., Sabarathinam, S., and Vijayakumar, T.M., 2022, Network pharmacology and in silico pharmacokinetic prediction of Ozanimod in the management of ulcerative colitis: A computational study, Health Science Reports, 5(1), e473. CrossRef
Suarez-Arnedo, A., Figueroa, F.T., Clavijo, C., Arbeláez, P., Cruz, J.C., and Muñoz-Camargo, C., 2020, An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays, PloS one, 15(7), e0232565. CrossRef
Susanti, N.M., Saputra, P., and Hendrayati, L.P., 2018, Molecular Docking Sianidin dan Peonidin sebagai Antiinflamasi pada Aterosklerosis Secara In Silico, Jurnal Farmasi Udayana, 7(1), 28. CrossRef
Tamirat, M.Z., Koivu, M., Elenius, K., and Johnson, M.S., 2019, Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation, PloS one, 14(9), e0222814. CrossRef
Torres, P.H., Sodero, A.C., Jofily, P., and Silva-Jr, F.P., 2019, Key topics in molecular docking for drug design, International Journal of Molecular Sciences, 20(18), 4574. CrossRef
Varella, L., and Cristofanilli, M., 2023, Evaluating elacestrant in the management of ER-positive, HER2-negative advanced breast cancer: evidence to date, OncoTargets and Therapy, 16, 189-196. CrossRef
Wang, S., Wan, D., Liu, W., Kang, X., Zhou, X., Sefidkon, F., et al., 2022, A Biflavonoid-Rich Extract from Selaginella doederleinii Hieron. against Throat Carcinoma via Akt/Bad and IKKβ/NF-κB/COX-2 Pathways, Pharmaceuticals, 15(12), 1505. CrossRef
World Health Organization, 2022, February 3, Cancer, Accesed on 5 June 2023 from World Health Organization International: https://www.who.int/news-room/fact-sheets/detail/cancer. Link
Xu, D., Wang, X., Huang, D., Chen, B., Lin, X., Liu, A., and Huang, J., 2022, Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics, Journal of Ethnopharmacology, 286, 114836. CrossRef
Zhuang, W.R., Wang, Y., Cui, P.F., Xing, L., Lee, J., Kim, D., et al., 2019, Applications of π-π stacking interactions in the design of drug- delivery systems, Journal of controlled release, 294, 311-326. CrossRef
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev15iss1pp1-17
Copyright (c) 2024 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
